Background Evidence is limited regarding the most effective pharmacological treatment for
psychotic depression: combination of an antidepressant plus an antipsychotic, monotherapy …

Background Evidence is limited regarding the most effective pharmacological treatment for
psychotic depression: monotherapy with an antidepressant, monotherapy with an …

Background There are no recommendations based on the efficacy of specific drugs for the
treatment of psychotic depression. To address this evidence gap, we did a network meta …

Background Depression is common, disabling, costly and under‐treated. There are
problems in the current first‐line drug treatment, antidepressants, for moderate or severe …

Objective: To perform a meta-analysis of antidepressant-antipsychotic cotreatment versus
antidepressant or antipsychotic monotherapy for psychotic depression. Data Sources: We …

Background Depressive symptoms, often of substantial severity, are found in 50% of newly
diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have …

Background. The number of trials on psychotherapies for adult depression is very large and
is quickly growing. Because of this large body of knowledge, it is important that the results of …

BackgroundThe optimal pharmacological treatment of unipolar psychotic depression is
uncertain. AimsTo compare the clinical effectiveness of pharmacological treatments for …

Background Behavioural therapies represent one of several categories of psychological
therapies that are currently used in the treatment of depression. However, the effectiveness …

BACKGROUND: Psychotic depression (PD) is a prevalent, severe, under-diagnosed and
often inadequately treated mental disorder, which has received disproportionally little …